These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


275 related items for PubMed ID: 9553430

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Tuberculostatics-induced systemic lupus erythematosus].
    Layer P, Engelhard M.
    Dtsch Med Wochenschr; 1986 Oct 17; 111(42):1603-5. PubMed ID: 3769804
    [Abstract] [Full Text] [Related]

  • 5. Effect of drug-induced hyperuricaemia on renal function in Nigerians with pulmonary tuberculosis.
    Adebisi SA, Oluboyo PO, Okesina AB.
    Afr J Med Med Sci; 2000 Oct 17; 29(3-4):297-300. PubMed ID: 11714010
    [Abstract] [Full Text] [Related]

  • 6. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T, Rehman F, Mitchison DA, Sarma GR, Reetha AM, Prabhaker R, Tuberculosis Research Centre, Indian Council of Medical Research.
    Trop Med Int Health; 2004 May 17; 9(5):551-8. PubMed ID: 15117298
    [Abstract] [Full Text] [Related]

  • 7. Current HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone-free antituberculosis treatment in Yaounde, Cameroon.
    Kuaban C, Bercion R, Koula-Shiro S.
    Cent Afr J Med; 1998 Feb 17; 44(2):34-7. PubMed ID: 9675969
    [Abstract] [Full Text] [Related]

  • 8. [Risk factors for the occurrence of eye damage following ethambutol treatment].
    Bastian A, Brandt HP.
    Z Erkr Atmungsorgane; 1987 Feb 17; 169(2):162-5. PubMed ID: 3687108
    [Abstract] [Full Text] [Related]

  • 9. Optic neuropathy in ethambutol-treated renal tuberculosis.
    DeVita EG, Miao M, Sadun AA.
    J Clin Neuroophthalmol; 1987 Jun 17; 7(2):77-86. PubMed ID: 2956288
    [Abstract] [Full Text] [Related]

  • 10. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM, Goldberg SV.
    Int J Tuberc Lung Dis; 2002 Nov 17; 6(11):952-8. PubMed ID: 12475140
    [Abstract] [Full Text] [Related]

  • 11. [Biochemical bases of adverse reactions to antibacterial preparations used in renal tuberculosis and means of their prevention].
    Kazakov KS, Chernik RB, Krivtsova MA.
    Probl Tuberk; 1989 Nov 17; (6):52-5. PubMed ID: 2771913
    [Abstract] [Full Text] [Related]

  • 12. [Case of fatal liver failure due to anti-tuberculous therapy].
    Harada Y, Kawakami K, Koyama K, Yamaryo T, Kimura Y.
    Kekkaku; 2007 Sep 17; 82(9):705-9. PubMed ID: 17969987
    [Abstract] [Full Text] [Related]

  • 13. [Adverse effects of antitubercular drugs: epidemiology, mechanisms, and patient management].
    Aouam K, Chaabane A, Loussaïef C, Ben Romdhane F, Boughattas NA, Chakroun M.
    Med Mal Infect; 2007 May 17; 37(5):253-61. PubMed ID: 17336011
    [Abstract] [Full Text] [Related]

  • 14. Alternative anti-tuberculosis regimen including ofloxacin for the treatment of patients with hepatic injury.
    Szklo A, Mello FC, Guerra RL, Dorman SE, Muzy-de-Souza GR, Conde MB.
    Int J Tuberc Lung Dis; 2007 Jul 17; 11(7):775-80. PubMed ID: 17609053
    [Abstract] [Full Text] [Related]

  • 15. [Tuberculostatics. General adverse effects].
    Mordasini ER, Eulenberger J.
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb 17; 5(4):499-518. PubMed ID: 4339952
    [No Abstract] [Full Text] [Related]

  • 16. [How to oversee the treatment of tuberculosis?].
    Germouty J, Serizay B, Demonet B, Charles A.
    Sem Hop; 1970 Jun 08; 46(27):1911-4. PubMed ID: 4316120
    [No Abstract] [Full Text] [Related]

  • 17. Is pyrazinamide really the third drug of choice in the treatment of tuberculosis?
    Koumbaniou C, Nicopoulos C, Vassiliou M, Manda-Stachouli C, Sakellariou K, Demou GS, Constantopoulos SH.
    Int J Tuberc Lung Dis; 1998 Aug 08; 2(8):675-8. PubMed ID: 9712283
    [Abstract] [Full Text] [Related]

  • 18. Should ethambutol be recommended for routine treatment of tuberculosis in children? A review of the literature.
    Trébucq A.
    Int J Tuberc Lung Dis; 1997 Feb 08; 1(1):12-5. PubMed ID: 9441051
    [Abstract] [Full Text] [Related]

  • 19. [Side effects of antitubercular drugs leading to discontinuation of drug therapy].
    Bergan S, Laake K, Bjartveit K.
    Tidsskr Nor Laegeforen; 1980 Feb 20; 100(5):279-82. PubMed ID: 7385151
    [No Abstract] [Full Text] [Related]

  • 20. Adverse reactions to drugs used in the treatment of tuberculosis.
    Nariman S.
    Adverse Drug React Acute Poisoning Rev; 1988 Feb 20; 7(4):207-27. PubMed ID: 3071113
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.